Perioperative Propranolol During Prostatectomy to Decrease Cancer Recurrence
Status:
Not yet recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the feasibility of conducting a larger randomized
controlled trial to assess the efficacy of perioperative propranolol capsules compared with
placebo capsules in decreasing recurrence of prostate cancer after robotic assisted
laparoscopic prostatectomy (RALP) in participants with intermediate to high-risk for prostate
cancer recurrence.